Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1825.83	-308.02	15.99
Graham Fair Price	-3.02	12.90	13.30
PEG	-378.37	-2.51	-0.52
Price/Book	7.32	1.11	1.04
Price/Cash Flow	159.46	65.75	25.34
Prices/Earnings	11.51	12.86	11.54
Price/Sales	-48.46	8.21	15.92
Price/FCF	159.46	65.75	25.34
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.69	0.99	1.00
Operating Margin	-89.78	0.21	-2.03
ROA	-7.53	< 0.005	< 0.005
ROE	0.02	0.02	-3.76
ROIC	-0.10	0.02	-81.53
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.51	-0.54	-6.28
Dividends QOQ	0.19	< 0.005	-99.33
EBIT QOQ	-4.71	1.21	-74.35
EPS QOQ	-0.22	-0.05	76.69
FCF QOQ	-0.07	-0.60	-790.92
Revenue QOQ	-0.39	1.04	165.77
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-17521.88	-100.00
Days Sales Outstanding (DSO)	48.77	22.94	-52.97
Inventory Turnover	0.00	< 0.005	-100.00
Debt/Capitalization	0.12	0.20	65.95
Quick Ratio	0.29	0.49	68.84
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.72	18.51	-1.15
Cash	34.29	39.98	16.58
Capex	-0.10	-0.13	-28.18
Free Cash Flow	0.76	0.31	-59.11
Revenue	1.22	2.50	105.83
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.07	0.15	134.27
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.46	177.51	3877.80
Naive Interpretation	Member

06 - Financial Health · Bad

Rating